Evolution of Regulatory Policy For Cell/Gene Therapy - a podcast by Pharma Talk Radio

In this podcast, first recorded at the 2021 IO360° Summit, Dr Peter Marks, Center for Biologics Evaluation and Research (CBER), FDA, moderated a panel on the evolution of regulatory policy for cell/gene therapy.

Discussion points include:
What are the greatest challenges to the expeditious development of cell and gene therapies at this time?How does the existing regulatory framework mesh with the current state of development of cell and gene therapy products?What adaptations or adjustments to the regulatory framework that might further advance manufacturing or clinical development of these products?Are there scientific developments coming that will require further adaptation or adjustment to the regulatory framework?
Panelists include:

Jeff Allen, PhD, Friends of Cancer Research

Anne Chew, PhD, University of Pennsylvania

Alberto Santagostino, Lonza Pharma & Biotech

To learn more about the upcoming 2021 IO360° conference, please visit www.io360summit.com

Further episodes of PharmaTalkRadio

Further podcasts by Pharma Talk Radio

Website of Pharma Talk Radio